Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC-MPS Combination in High Risk Kidney Transplant
NCT00154232Phase 4Completed
- Sponsor
- Novartis
- Start
- Jun 2004
- Primary completion
- Mar 2005
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of mycophenolate sodium in kidney transplant rejection, sponsored by Novartis. Started Jun 2004; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00154232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154232.